Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite

Canadian Journal of Physiology and Pharmacology
C A GruetterL J Ignarro

Abstract

Relaxation by nitroglycerin, sodium nitrite, and amyl nitrite of bovine coronary arterial smooth muscle was inhibited by the oxidant methylene blue. Methylene blue also inhibited activation of bovine coronary arterial soluble guanylate cyclase by nitroglycerin, which required addition of cysteine. At concentrations less than 10 mM, sodium nitrite required the addition of one of several thiols or ascorbate to activate guanylate cyclase from bovine coronary artery. Guanylate cyclase activation by large amounts (50 microL) of saturated amyl nitrite gas did not require, but was enhanced by, the addition of thiols or ascorbate. However, similar to sodium nitrite, guanylate cyclase activation by smaller amounts (5 microL) of saturated amyl nitrite gas did require the addition of one of various thiols or ascorbate. Methylene blue markedly inhibited guanylate cyclase activation by sodium nitrite in the presence of cysteine or ascorbate and similarly inhibited enzyme activation by amyl nitrite either in the absence or presence of cysteine or ascorbate. These data support the hypothesis that nitrates and nitrites relax vascular smooth muscle by stimulating cyclic GMP formation. The results further suggest that, similar to relaxation and ...Continue Reading

Citations

Apr 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·W R KukovetzG Pöch
Jun 1, 2011·European Journal of Nutrition·Ajay Machha, Alan N Schechter
Jan 26, 1993·Biochemical Pharmacology·B MayerK Schmidt
Apr 23, 1985·European Journal of Pharmacology·C A Gruetter, S M Lemke
Nov 26, 1985·European Journal of Pharmacology·H C Huang, C Y Lee
Mar 11, 1986·European Journal of Pharmacology·K Schmidt, W R Kukovetz
Mar 31, 1987·European Journal of Pharmacology·N TodaT Okamura
Apr 27, 1988·European Journal of Pharmacology·L J IgnarroG Chaudhuri
Nov 1, 1988·European Journal of Pharmacology·H KarakiK Murakami
Jun 22, 1988·European Journal of Pharmacology·N TodaH Onoue
Feb 14, 1989·European Journal of Pharmacology·G M BugaL J Ignarro
Aug 14, 1992·European Journal of Pharmacology·F N KoC M Teng
Nov 2, 1993·European Journal of Pharmacology·K IwatsukiS Chiba
Jan 14, 1994·European Journal of Pharmacology·N SuzukiY Gomi
Jan 4, 1994·European Journal of Pharmacology·N SatakeS Shibata
Oct 1, 1992·Toxicon : Official Journal of the International Society on Toxinology·A YaraM Sakanashi
Jan 1, 1991·General Pharmacology·N SatakeS Shibata
May 1, 1992·General Pharmacology·N SatakeS Shibata
Jan 1, 1994·General Pharmacology·A TakeuchiN Ogawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.